BSX Stock Recent News

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Boston Scientific (BSX) concluded the recent trading session at $87, signifying a +0.27% move from its prior day's close.

Boston Scientific (BSX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Boston Scientific (BSX) is well positioned to outperform the market, as it exhibits above-average growth in financials.

BSX is expected to have registered strong growth in the Asia Pacific, which is led by strength in China and Japan.

Boston Scientific (BSX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Investors interested in stocks from the Medical - Products sector have probably already heard of Haemonetics (HAE) and Boston Scientific (BSX). But which of these two stocks is more attractive to value investors?

DENVER--(BUSINESS WIRE)-- #Cerebralembolicprotection--Transverse Medical, Inc., developer of the POINT-GUARD™ Cerebral Embolic Protection medical device, is pleased to announce the appointment of Ian T. Meredith, MD to the Board of Directors. Professor Meredith brings over 35 years of experience and global leadership in cardiology coupled with successful clinical trials and device commercialization of multiple interventional devices. Professor Ian Meredith, MD has agreed to join the Company's Board of Directors as an Indep.

Here is how Boston Scientific (BSX) and Arcellx, Inc. (ACLX) have performed compared to their sector so far this year.

Royal Caribbean Cruises, Boston Scientific and Monolithic Power Systems have been selected as the top picks with a high net income ratio.